FDA NDC Directory · JSON-LD · Markdown

Fulvestrant

NDC 68001-484 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA210044
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR
Active ingredientsFULVESTRANT (250 mg/5mL)
Marketing started20210301
Package count1

External sources

Source: openFDA. Public-domain (CC0).